- Sidus Space, Inc. (NASDAQ:SIDU) has signed a memorandum of understanding with Exo-Space to further commercialize its satellite edge computing technology.
- Under this partnership, Sidus Space will integrate Exo-Space’s FeatherEdge Data Processing Platform into its hybrid 3D printed satellite, LizzieSat.
- The collaborative technology implementation will provide near-real-time intelligence derived from Earth Observation data while onboard the satellite, helping commercial and government customers to take more effective action in time-sensitive operations.
- “We are excited to partner with Exo-Space to provide proof-of-concept for its critically important technology and a long-term path for providing real-time solutions,” said Carol Craig, Sidus CEO/Founder.
- Price Action: SIDU shares are trading lower by 1.71% at $2.69 on the last check Tuesday.
Sanofi In-Licenses Pompe Disease Therapy From Privately-Held Maze Therapeutics For $150M Upfront
Maze Therapeutics has signed an exclusive worldwide license agreement with Sanofi SA (NASDAQ: SNY) for Maze's glycogen synthase 1 (GYS1) program, including clinical candidate MZE001, which is currently in development for the treatment of Pompe disease and
